Shares of Bruker Biosciences gained 13.4 percent for the trading week ended Tuesday, reversing a 7-percent decline the week before. The firm led the seven companies in the BCW Index that gained ground for the tracking period. Stratagene led decliners in the Index with a drop of 9.3 percent. Its shares reached a 52-week low of $5.51 on Tuesday before closing at $5.67.

Overall, the Index gained .1 percent for the week. In comparison, the Dow Jones Industrial Average fell .5 percent, the Nasdaq dropped .3 percent, and the Nasdaq Biotech Index declined .7 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.